Phase II study of 6-thioguanine, procarbazine, dibromodulcitol, lomustine, and vincristine chemotherapy with radiotherapy for treating malignant glioma in children

Neuro-Oncology

Volumn 2, Issue 1, 2000, Pages 22-28

  Levin, V A ^a,d   Lamborn, Kathleen ^b   Wara, William ^b   Davis, Richard ^c   Edwards, Michael ^b   Rabbitt, Jane ^b   Malec, Mary ^b   Prados, Michael D ^b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; LOMUSTINE; MITOLACTOL; PROCARBAZINE; TIOGUANINE; TPDCV PROTOCOL; VINCRISTINE;

ADOLESCENT; ADULT; ARTICLE; BRAIN TUMOR; CHILD; CLINICAL TRIAL; FEMALE; GLIOMA; HUMAN; MALE; MULTIMODALITY CANCER THERAPY; PHASE 2 CLINICAL TRIAL; PRESCHOOL CHILD; SURVIVAL; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; FEMALE; GLIOMA; HUMANS; LOMUSTINE; MALE; MITOLACTOL; PROCARBAZINE; SURVIVAL ANALYSIS; THIOGUANINE; TREATMENT OUTCOME; VINCRISTINE;

EID: 0033754923     PISSN: 15228517     EISSN: None     Source Type: Journal    
DOI: 10.1093/neuonc/2.1.22     Document Type: Article

References (27)

1. Berger, M.S., Leibel, S.A., Bruner, J.M., Finlay, J.L., and Levin, V.A. (1996) Primary central nervous system tumors of the supratentorial compartment. In: Levin, V.A. (Ed.), Cancer in the Nervous System. New York: Churchill Livingstone. pp. 57-125.
2. Bodeli, W.J., Morgan, W.F., Rasmussen, J., Williams, M.E., and Deen, D.F. (1985) Potentiation of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU)-induced cytotoxicity in 9L cells by pretreatment with 6-thioguanine. Biochem. Pharmacol. 34, 515-520.
3. Burger, P.C., Scheithauer, B.W., and Vogel, F.S. (1991) Surgical Pathology of the Nervous System and its Coverings. Third edition. New York: Churchill Livingstone. pp. 214-23.
4. Finlay, J.L., Boyett, J.M., Yates, A.J., Wisoff, J.H., Milstein, J.M., Geyer, J.R., Bertolone, S.J., McGuire, P., Cherlow, J.M., and Tefft, M. (1995) Randomized phase III trial in childhood high-grade astrocytoma comparing vincristine, lomustine, and prednisone with the eight-drugs-in-1-day regimen. Children's Cancer Group. J. Clin. Oncol. 13, 112-123.
5. Florell, R.C., Macdonald, D.R., Irish W.D., Bernstein, M., Leibel, S.A., Gutin, P.H., and Caimcross, J.G. (1992) Selection bias, survival, and brachytherapy for glioma. J. Neurosurg. 76, 179-183.
6. Fujimoto, S., Ogawa, M., and Sakurai, Y. (1982) Hypothetical mechanism of therapeutic synergism induced by the combination of 6-thioguanine and 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea hydrochloride. Cancer Res. 42, 4079-4085.
7. Goldwein, J.W., Glauser, T.A., Packer, R.J., Finlay, J.L., Sutton, L.N., Curran, W.J., Laehy, J.M., Rorke, L.B., Schut, L., and D'Angio, G.J. (1990) Recurrent intracranial ependymomas in children: Survival, patterns of failure, and prognostic factors. Cancer 66, 557-563.
8. Hunter, K.J., Deen, D.F., and Marton, L.J. (1989) Differential response to 1,3-bis (2-chloroethyl)-1-nitrosourea in drug-resistant and -sensitive 9L rat brain tumor cells pretreated with α-difluoromethylornithine and 6-thioguanine. Int. J. Cancer 44, 658-660.
9. Kaplan, E.L., and Meier, P. (1958) Nonparametric estimates from incomplete observations. J. Am. Stat Assoc. 53, 457-481.
10. Kovalic, J.J., Flaris, N., Grigsby, P.W., Pirkowski, M., Simpson, J.R., and Roth, K.A. (1993) Intracranial ependymoma long term outcome, patterns of failure. J. Neurooncol. 15, 125-131.
11. Levin, V.A., and Wheeler, K.T. (1982) Chemotherapeutic approaches to brain tumors: Experimental observations with dianhydrogalactitol and dibromodulcitol. Cancer Chemother. Pharmacol. 8, 125-131.
12. Levin, V.A., and Wilson, C.B. (1978) Correlations between experimental chemotherapy in the murine glioma and effectiveness of clinical therapy regimens. Cancer Chemother. Pharmacol. 1, 41-48.
13. Levin, V.A., Crafts, D.C., Norman, D.M., Hoffer, P.B., Spire, J.P., and Wilson, C.B. (1977) Criteria for evaluating patients undergoing chemotherapy for malignant brain tumors. J. Neurosurg. 47, 329-335.
14. Levin, V.A., Leibel, S.A., and Gutin, P.H. (1997) Neoplasms of the central nervous system. In DeVita, V.T., Jr., Hellman, S., and Rosenberg, S.A. (Eds.), Cancer: Principles and Practice of Oncology, Vol. 2. Fifth edition. Philadelphia: Lippincott-Raven. pp. 2022-2082.
15. Loeffler, J.S., Alexander, E., III, Shea, W.M., Wen, P.Y., Fine, H.A., Kooy, H.M., and Black P.M. (1992) Radiosurgery as part of the initial management of patients with malignant gliomas. J. Clin. Oncol. 10, 1379-1385.
16. Lyons, M.K., and Kelly, P.J. (1991) Posterior foss ependymomas: Report of 30 cases and review of the literature. Neurosurgery 28, 659-664.
17. 6-alkylguanine-DNA alkyltransferase in vivo by pretreatment with anitineo-plastic agents. Biochem. Pharmacol. 38, 929-934.
18. Prados, M.D., Edwards, M.S.B., Rabbitt, J., Lambom, K., Davis, R.L., and Levin, V.A. (1997) Treatment of pediatric low-grade gliomas with a nitrosourea-based multiagent chemotherapy regimen. J. Neurooncol. 32, 235-241.
19. Prados, M.D., Larson, D.A., Lamborn, K., McDermott, M.W., Sneed, P.K., Wara, W.M., Chang, S.M., Mack, E.E., Krouwer, H.G.J., Chandler, K.L., Warnick, R.E., Davis, R.L, Rabbitt, J.E., Malec, M., Levin, V.A., Gutin, P.H., Phillips, T.L., and Wilson, C.B. (1998) Radiation therapy and hydroxyurea followed by the combination of 6-thioguanine and BCNU for the treatment of primary malignant brain tumors. Int. J. Radiat. Oncol. Biol. Phys. 40, 57-63.
20. Pulst, S.M., Levin, V.A., and Deen, D.F. (1986) In vitro cytotoxic effects of dibromodulcitol in 9L rat brain tumor cells. Pharm. Res. 3, 302-306.
21. Ringertz, N. (1950) "Grading" of gliomas. Acta. Pathol. Microbiol. Scand. 27, 51-64.
22. Robertson, P.L., Zeltzer, P.M., Boyett, J.M., Rorke, L.B., Allen, J.C., Geyer, J.R., Stanley, P., Li, H., Albright, A.L., McGuire-Cullen, P., Finlay, J.L., Stevens, K.R., Jr., Milstein, J.M., Packer, R.J., and Wisoff, J. (1998) Survival and prognostic factors following radiation therapy and chemotherapy for ependymomas in children: A report of the Children's Cancer Group. J.Neurosurg. 88, 695-703.
23. Schiffer, D., Chio, A., Cravioto, H., Giordana, M.T., Migheli, A., Soffietti, R., and Vigliani, M.C. (1991) Ependymoma: Internal correlations among pathological signs: The anaplastic variant. Neurosurg. 29, 206-210.
24. 6-alkylguanine-DNA alkyltransferase and sensitivity to procarbazine in human brain-tumor xenografts. J. Neurosurg. 70, 573-577.
25. Shaw, E.G., Evans, R.G., Scheithauer, B.W., Ilstrup, D.M., and Earle, J.D. (1987) Postoperative radiotherapy of intracranial ependymoma in pediatric and adult patients. Int. J. Radiat. Oncol. Biol. Phys. 13, 1457-1462.
26. 6-alkylguanine-DNA alkyltransferase in rat tissues. Carcinogenesis 15, 1681-1688.
27. Weinkam, R.J., and Shiba, D.A. (1978) Metabolic activation of procarbazine. Life Sci. 22, 937-945.